Conference Proceedings

Abstract CT039: INDUCE-1: a phase I open-label study of GSK3359609, an ICOS agonist antibody, administered alone and in combination with pembrolizumab in patients with selected, advanced solid tumors

Eric Angevin, Todd M Bauer, Catherine E Ellis, Hui Gan, Rigel Hall, Aaron Hansen, Axel Hoos, Roxanne C Jewell, Jessica Katz, Juan Martin-Liberal, Michele Maio, Patrick A Mayes, Jolly Mazumdar, Michael Millward, Danny Rischin, Jan H Schellens, Sapna Yadavilli, Helen Zhou

Clinical Trials | American Association for Cancer Research | Published : 2017